Congress 2014 has ended
Back To Schedule
Thursday, May 1 • 11:15am - 12:15pm
A New Treatment Option in Previously Treated Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

This theater presentation will introduce a new oral treatment option in previously treated chronic lymphocytic leukemia and mantle cell lymphoma. Speakers will discuss the safety and efficacy profile of a new treatment option, identify patients, and review recommended dosing and administration. 

This promotional educational activity is not accredited.

In adherence with the Janssen Biotech, Inc., and Pharmacyclics, Inc., PhRMA guidelines, spouses or other guests are not permitted to attend company-sponsored programs. For all attendees, please be advised that information related to the event, such as your name and the value and purpose of any educational item, meal, or other items of value you receive may be publicly disclosed. If you are licensed in any state or other jurisdiction, or are an employee or contractor of any organization or governmental entity that limits or prohibits meals from pharmaceutical companies, please identify yourself so that you (and we) are able to comply with such requirements. Thank you for your cooperation.

The program content is developed by Janssen Biotech, Inc., and Pharmacyclics, Inc. Speakers present on disease state education on behalf of the company and are required to present information in compliance with FDA requirements about its medicines. The personal information you provide will be used to contact you about your request to attend the Janssen Biotech, Inc., and Pharmacyclics, Inc., educational program using your preferred method of communication as indicated by you. This information will be shared with Janssen Biotech, Inc., and Pharmacyclics, Inc., their affiliates, and a third party for the purpose of completing your registration for this program and as required by law.

Sponsored by Pharmacyclics, Inc., and Janssen Biotech, Inc., in partnership with ONS:Edge, Inc., a subsidiary of the Oncology Nursing Society.

This event qualifies for the ONS:Edge Unlock the Levels of Learning contest. Seating is on a first-come, first-served basis. Please plan to arrive early to have the best chance at securing your seat. 

Thursday May 1, 2014 11:15am - 12:15pm PDT
Theater 2, Hall B Anaheim Convention Center, 800 W. Katella Ave, Anaheim, CA 92802
  Industry Event
  • CNE Status No CNE
  • Contact Hours of CNE: N/A

Attendees (0)